Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 21, 2026 · Filed Oct 22, 2026
An Agomab Therapeutics director paid $44K out of pocket for Agomab Therapeutics shares. 2 other people at Agomab Therapeutics bought some too, in the same month. Shares held went up 33% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Written by software from the filings listed below · Oct 23, 2026
5 more points, with the facts they come from, are in OQRO Pro.
Sign up freeopen market purchase
Code P — open-market or private purchase
~$44,300
Shares × reported transaction price
$25K–$100K
+33.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 3 earlier confirmed purchases
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −17.2% | −0.6% | −16.7% |
Past results only. Not a forecast.
Insider buying
Traded Nov 5 · filed 1 day later
An Agomab Therapeutics director paid $34K out of pocket for Agomab Therapeutics shares. 2 other people at Agomab Therapeutics bought some too, in the same month. Shares held went up 20% with this purchase.
Insider buying
Traded Nov 5 · filed 1 day later
An Agomab Therapeutics director paid $35K out of pocket for Agomab Therapeutics shares. 2 other people at Agomab Therapeutics bought some too, in the same month. Shares held went up 17% with this purchase.
Insider buying
Traded Nov 5 · filed 1 day later
An Agomab Therapeutics director paid $35K out of pocket for Agomab Therapeutics shares. 2 other people at Agomab Therapeutics bought some too, in the same month. Shares held went up 14% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.